Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Coriolis Pharma Adds Analytical Ultracentrifugation to Its Service Offerings | Contract Pharma

What are you searching for?

Sign in
Breaking News

Coriolis Pharma Adds Analytical Ultracentrifugation to Its Service Offerings

Expands its existing portfolio of GMP methods for the development of drug products.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Coriolis Pharma, a globally operating service provider for drug product development, analytics and manufacturing support, has introduced Analytical Ultracentrifugation (AUC) under GMP, thereby meeting the increasing demand in the pharmaceutical and biotech industry and expanding its existing portfolio of GMP methods for the development of high-quality drug products.
 
AUC is recognized as a powerful technique for the detailed study of macromolecules, including proteins, nucleic acids, viral vectors, and nanoparticles. According to Coriolis, its ability to provide precise information on aggregation, molecule size, shape and interactions has made it indispensable in the field of biophysical characterization.
 
“Coriolis has been a world leading specialist for biopharmaceutical method development and testing by using AUC for almost a decade, featuring all available combinations of state-of-the-art AUC hard- and software,” said Dr. Frank Schaubhut, Head of Operations at Coriolis Pharma. “We’re proud to take our expertise to the next quality level with introducing this service under GMP.”
 
From the early development to post-market monitoring: AUC has proven its versatility in the various phases of drug development: Formulation development, quality control, comparability studies or post-marketing surveillance. It is therefore an important addition to Coriolis’ range of phase-appropriate analytical services under GMP, which also includes method development and validation, compendial method verification, release testing, tech transfer support, and stability testing.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics